As a reminder, effective for dates of service on and after March 1, 2018, a quantity limit will apply to all preferred and non-preferred stimulants, with the exception of liquid dosage forms of stimulants. The quantity limit for stimulants (with the exception of liquid dosage forms) will have a cumulative quantity limit of 136 units per month across the stimulants drug class.

In order to prepare for this upcoming quantity limit, ForwardHealth will allow a one-time stimulant quantity limit override to be requested during the transition period from March 1, 2018, through March 31, 2018, so that pharmacy providers can work with prescribers to consolidate, adjust, or change members’ stimulant medications and dosages, as appropriate.

To request an override of the new quantity limit from March 1, 2018, through March 31, 2018, providers may call the Drug Authorization and Policy Override (DAPO) Center at 800-947-9627. Hours of operation are from 8:00 a.m. to 5:30 p.m. CST, Monday through Friday. After business hours and on weekends, providers may leave a voicemail message for DAPO Center staff to return the next business day.

Providers may refer to the Quantity Limit Drugs and Diabetic Supplies data table for the most current quantity limits for all ForwardHealth drugs and diabetic supplies.

Pharmacy providers are reminded that they may dispense up to the allowed quantity limit without contacting the DAPO Center.

For more information about the quantity limit policy for stimulants, providers may refer to the Quantity Limits topic (topic #3444) in the Submission chapter of the Claims section of the Pharmacy service area of the Online Handbook.